Replies to post #2983 on Value Microcaps Zip Code Changers

[bbotcs]

stock_peeker: VVUS

Encouraging news, but will this be one of the rare cases where the FDA went against the panel's recommendation? I'm not optimistic. One of the panel's concerns about QNEXA is its long-term side effects. The study results today seem to mitigate those concerns, though it might be too late. IMO the company should have delayed going before the FDA panel until after today's study results were announced. They took a big gamble and lost.

Speaking of gambles, I'm in at $7.25 for a trade.